Seller record · joinweightcare.com

WeightCare

Recorded September 2026 · Standard v1.1

Fails 3 of 8 criteria. S3, pharmacy identification: The site names no filling pharmacy. About, questions, terms, refund and privacy pages stop at an accredited compounding pharmacy partner. 2 more criteria also fail; see the table below.

Telehealth service. Passes 4 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide and tirzepatide on three-month and six-month plans. It prints its renewal prices in full and names none of the compounding pharmacies it says it works with.

Operating entity The footer, the about page, the terms of service and the privacy policy were all read, and none of the four prints a legal entity name.

Dispositions

Code	Criterion	Disposition	Where it was read
S1	Prescriber requirement	PASS	joinweightcare.com/pages/about
S2	Prescription gating	NOT VERIFIED	joinweightcare.com/pages/how-it-works
S3	Pharmacy identification	FAIL	joinweightcare.com/pages/about
S4	Compounding disclosure	FAIL	joinweightcare.com/pages/faq
S5	Analytical documentation	FAIL	joinweightcare.com/pages/faq
S6	Business address	PASS	joinweightcare.com/policies/privacy-policy
S7	Price disclosure	PASS	joinweightcare.com/pages/faq
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1PASSBoard-certified physicians treat every patient, and no individual prescriber is named on the site.Source: joinweightcare.com/pages/about.

S2NOT VERIFIEDThe eligibility quiz the site advertises did not resolve, because no link on any page reaches it. The check is open.Source: joinweightcare.com/pages/how-it-works.

S3FAILThe site names no filling pharmacy. About, questions, terms, refund and privacy pages stop at an accredited compounding pharmacy partner.Source: joinweightcare.com/pages/about.

S4FAILThe site sells compounded drugs and never states that they lack Food and Drug Administration approval. Its one disclosure calls a compounded drug an alternative to approved brands.Source: joinweightcare.com/pages/faq.

S5FAILNo certificate, lot number or purity figure appears anywhere on the site.Source: joinweightcare.com/pages/faq.

S6PASSThe privacy policy prints a street address with a unit number on South Federal Highway in Fort Lauderdale, Florida.Source: joinweightcare.com/policies/privacy-policy.

S7PASSThe questions page prints four renewal prices: 499 dollars monthly, 997 dollars for three months, 1350 dollars for three months at the higher dose and 2150 dollars for six.Source: joinweightcare.com/pages/faq.

S8PASSFDA warning letter 721478, February 2026, names Weightless Medical LLC doing business as WeightCare and alleges the pictured label presents WeightCare as the compounder when it is not. No FDA action has halted the business, and the seller still trades.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, health coaching.

Enforcement documents on file: 1 warning letter

FDA warning letter 721478, issued February 2026, to Weightless Medical LLC dba WeightCareThe pictured label on joinweightcare.com names WeightCare as the compounder of its semaglutide and tirzepatide when it is not.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.